- Home
- RITM vs BHVN Comparison
RITM vs BHVN Comparison
Compare RITM & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RITM
- BHVN
- Stock Information
- Founded
- RITM 2011
- BHVN 2013
- Country
- RITM United States
- BHVN United States
- Employees
- RITM N/A
- BHVN N/A
- Industry
- RITM Real Estate Investment Trusts
- BHVN Biotechnology: Pharmaceutical Preparations
- Sector
- RITM Real Estate
- BHVN Health Care
- Exchange
- RITM Nasdaq
- BHVN Nasdaq
- Market Cap
- RITM 5.5B
- BHVN 5.4B
- IPO Year
- RITM N/A
- BHVN 2017
- Fundamental
- Price
- RITM $10.73
- BHVN $44.39
- Analyst Decision
- RITM Strong Buy
- BHVN Strong Buy
- Analyst Count
- RITM 10
- BHVN 13
- Target Price
- RITM $12.65
- BHVN $63.42
- AVG Volume (30 Days)
- RITM 4.4M
- BHVN 725.9K
- Earning Date
- RITM 10-29-2024
- BHVN 11-12-2024
- Dividend Yield
- RITM 9.33%
- BHVN N/A
- EPS Growth
- RITM N/A
- BHVN N/A
- EPS
- RITM 0.99
- BHVN N/A
- Revenue
- RITM $3,006,456,000.00
- BHVN N/A
- Revenue This Year
- RITM N/A
- BHVN N/A
- Revenue Next Year
- RITM $4.33
- BHVN $179.00
- P/E Ratio
- RITM $10.86
- BHVN N/A
- Revenue Growth
- RITM 1.78
- BHVN N/A
- 52 Week Low
- RITM $9.97
- BHVN $26.80
- 52 Week High
- RITM $12.02
- BHVN $62.21
- Technical
- Relative Strength Index (RSI)
- RITM 49.14
- BHVN 33.48
- Support Level
- RITM $10.68
- BHVN $51.80
- Resistance Level
- RITM $10.89
- BHVN $54.53
- Average True Range (ATR)
- RITM 0.18
- BHVN 2.42
- MACD
- RITM 0.05
- BHVN -0.92
- Stochastic Oscillator
- RITM 68.00
- BHVN 9.80
About RITM Rithm Capital Corp.
Rithm Capital Corp operates as a real estate investment trust that provides capital and services to the real estate and financial services industries. The company's mission is to generate attractive risk-adjusted returns in all interest-rate environments through a complementary portfolio of investments and operating businesses. Rithm Capital's investment portfolio is composed of mortgage servicing-related assets (full and excess MSRs and servicer advances), residential securities (and associated call rights) loans (including single-family rental), and consumer loans.
About BHVN Biohaven Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. Its products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.